Tender Details
Tender Title / Description
| Tender Title | Drug Tender |
|---|---|
| Tender Description | 2% lignocain jelly 30 gm. 4% lignocain topical 50 ml. anti d immunoglobulin 100 mg cap astymin m forte cap. cyclosporine 50 mg cap. danazole 50 mg. cap. dexrabiprazole 10 mg + domperidone 30 mg sr cap. isotretinoin 20 mg cap. minocycline 100 mg cap. nifedipine sub lingual 5 mg cap. nifedipine soft gelatin 5 mg cap. pepsin (1:3000) 12.5 mg+ fungal dystase (1:2000 ) 18.75 mg cap. spores of poly antibiotic resistant bacillus clausi ii , 2 billion spores cap. vitamin e 200 mg. carbolic acid 400 ml clotrimazole v. tab. colloid cream betamethasone 20 gm. cream framycetin skin cream cream hydrocortisone 1% ct contrast media non ionic iohexol 350 /100 ml polymer bottle, usfda approved e/d bromofenac 0.075% e/d fluconazole 2% e/d latanoprost 05% e/d loteprednol 0.2% e/d natamycin 5% e/d nepafenac 0.1% e/d nephazoline 0.1%+ chlorpheniramine 0.01%+ hydroxypropyl methyl cellulose 0.25% e/d pilocarpine e/d prednisolone acitate e/d tropicamide with phenylnephrine e/o acyclovir e/o atropin |
| Comments | 2% lignocain jelly 30 gm. 4% lignocain topical 50 ml. anti d immunoglobulin 100 mg cap astymin m forte cap. cyclosporine 50 mg cap. danazole 50 mg. cap. dexrabiprazole 10 mg + domperidone 30 mg sr cap. isotretinoin 20 mg cap. minocycline 100 mg cap. nifedipine sub lingual 5 mg cap. nifedipine soft gelatin 5 mg cap. pepsin (1:3000) 12.5 mg+ fungal dystase (1:2000 ) 18.75 mg cap. spores of poly antibiotic resistant bacillus clausi ii , 2 billion spores cap. vitamin e 200 mg. carbolic acid 400 ml clotrimazole v. tab. colloid cream betamethasone 20 gm. cream framycetin skin cream cream hydrocortisone 1% ct contrast media non ionic iohexol 350 /100 ml polymer bottle, usfda approved e/d bromofenac 0.075% e/d fluconazole 2% e/d latanoprost 05% e/d loteprednol 0.2% e/d natamycin 5% e/d nepafenac 0.1% e/d nephazoline 0.1%+ chlorpheniramine 0.01%+ hydroxypropyl methyl cellulose 0.25% e/d pilocarpine e/d prednisolone acitate e/d tropicamide with phenylnephrine e/o acyclovir e/o atropin |
Important Dates
| Published Date | |
|---|---|
| Due Date | 03 Jan 2026 00:00:00 |
Estimate and EMD
| Estimated Value | 0.0 |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |